Cost Analysis of Vascular Surgical Techniques

NCT06367803 | Completed

• 1 other identifier: DVS010
• Study Type: observational
• Target: 200
• Locations: 1 country
• Sites: 1

Brief Summary

Whilst mortality rates and surgical limitations are widely known and understood for each intervention performed, the cost implications, in UHL, are not known. Therefore, it is deemed a matter of interest to understand these costs and weigh them against the mortality rates for each intervention if available.

Conditions

Critical Limb Ischemia

Outcome Measures

Primary Outcomes (1)

• A comparative assessment of the cost implications of the surgical modalities used in the treatment of CLTI i.e., revascularisation and amputation.

  A comparative assessment of the cost implications of the surgical modalities used in the treatment of CLTI i.e., revascularisation and amputation.

  2 years

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

Patients who have been diagnosed with CLTI and are under the care of a Vascular Surgeon at University Hospital Limerick

You may qualify if:

• Cases where CLTI was treated surgically by a Vascular Consultant at UHL will be included in this analysis. That being individuals who underwent revascularisation procedures and/or lower limb amputation.
• This analysis will look at cases from a set time frame, that being 1st March 2022 to 1st March 2023.

You may not qualify if:

• Cases where CLTI was treated conservatively/without surgical intervention will not be included.
• Surgical intervention outside of UHL.
• Cases that occurred outside of the set timeframe.

Sponsors & Collaborators

• University Hospital of Limerick: lead

Study Sites (1)

University Hospital Limerick

Limerick, Munster, Ireland

Location

MeSH Terms

Conditions

Chronic Limb-Threatening Ischemia

Condition Hierarchy (Ancestors)

Peripheral Arterial Disease; Atherosclerosis; Arteriosclerosis; Arterial Occlusive Diseases; Vascular Diseases; Cardiovascular Diseases; Peripheral Vascular Diseases; Chronic Disease; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms; Ischemia

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: April 11, 2024
• First Posted: April 16, 2024
• Study Start: June 1, 2023
• Primary Completion: December 1, 2023
• Study Completion: March 1, 2024
• Last Updated: May 4, 2025

Record last verified: 2025-04

Data Sharing

• IPD Sharing: Will share

Locations

IE (1)